Intra-Cellular Therapies Company Profile (NASDAQ:ITCI)

About Intra-Cellular Therapies

Intra-Cellular Therapies logoIntra-Cellular Therapies, Inc. (ITI) is a biopharmaceutical company. The Company is focused on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system (CNS). The Company's pipeline includes approximately two product candidates in clinical development and two product candidates in advanced pre-clinical testing. Its platform includes ITI-007 platform and phosphodiesterase (PDE) Inhibitor Platform. It is developing its lead drug candidate, ITI-007, for the treatment of schizophrenia, behavioral disturbances associated with dementia, autism and other CNS diseases. Its ITI-007 platform also includes long acting injectable (LAI) program, and IC200131 program for mood and other disorders. Its PDE Inhibitor Platform includes PDE1 program and PDE2 and PDE9 programs.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ITCI
  • CUSIP:
Key Metrics:
  • Previous Close: $40.38
  • 50 Day Moving Average: $40.82
  • 200 Day Moving Average: $35.26
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -13.20
  • P/E Growth: 0.00
  • Market Cap: $1.75B
  • Outstanding Shares: 43,251,000
  • Beta: 0.8
Additional Links:
Companies Related to Intra-Cellular Therapies:

Analyst Ratings

Consensus Ratings for Intra-Cellular Therapies (NASDAQ:ITCI) (?)
Ratings Breakdown: 7 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 3.13)
Consensus Price Target: $74.38 (84.19% upside)

Analysts' Ratings History for Intra-Cellular Therapies (NASDAQ:ITCI)
Show:
DateFirmActionRatingPrice TargetDetails
8/11/2016Leerink SwannReiterated RatingBuy$95.00View Rating Details
8/5/2016Cowen and CompanyReiterated RatingBuy$75.00View Rating Details
6/22/2016Piper Jaffray Cos.Reiterated RatingOverweight$57.00View Rating Details
3/29/2016SunTrust Banks Inc.Reiterated RatingTop Pick$60.00View Rating Details
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$62.00 -> $55.00View Rating Details
11/6/2015Royal Bank Of CanadaBoost Price TargetOutperform$62.00 -> $74.00View Rating Details
9/29/2015GuggenheimBoost Price TargetBuy$95.00 -> $104.00View Rating Details
9/17/2015Ladenburg ThalmannReiterated RatingBuy$54.00 -> $75.00View Rating Details
(Data available from 8/29/2014 forward)

Earnings

Earnings History for Intra-Cellular Therapies (NASDAQ:ITCI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/4/2016Q216($0.79)($0.71)$0.02 million$0.23 millionViewN/AView Earnings Details
4/28/2016Q116($0.78)($0.64)$0.02 millionViewListenView Earnings Details
2/25/2016Q415($0.87)($0.67)$0.05 million$30.66 millionViewListenView Earnings Details
11/5/2015Q315($0.66)($0.91)ViewN/AView Earnings Details
8/5/2015Q215($0.72)($0.61)$40.00 million$57.40 millionViewN/AView Earnings Details
4/30/2015Q1($0.68)($0.72)ViewN/AView Earnings Details
3/12/2015($0.49)($0.52)ViewN/AView Earnings Details
11/3/2014Q314($0.28)($0.22)ViewN/AView Earnings Details
8/12/2014Q214($0.23)($0.15)ViewN/AView Earnings Details
5/8/2014($0.23)($0.17)ViewN/AView Earnings Details
3/26/2014($0.41)($0.36)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Intra-Cellular Therapies (NASDAQ:ITCI)
Current Year EPS Consensus Estimate: $-3.16 EPS
Next Year EPS Consensus Estimate: $-3.06 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.74)($0.63)($0.69)
Q2 20162($0.79)($0.65)($0.72)
Q3 20163($0.82)($0.66)($0.71)
Q4 20161($0.93)($0.93)($0.93)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Intra-Cellular Therapies (NASDAQ:ITCI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Intra-Cellular Therapies (NASDAQ:ITCI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/29/2016Christopher D AlafiDirectorBuy100,000$29.70$2,970,000.00View SEC Filing  
12/15/2015Lawrence J. HinelineCFOSell45,000$51.45$2,315,250.00View SEC Filing  
12/11/2015Sharon MatesCEOSell51,500$53.87$2,774,305.00View SEC Filing  
12/8/2015Joel S MarcusDirectorSell92,700$54.47$5,049,369.00View SEC Filing  
11/24/2015Lawrence J HinelineCFOSell5,000$55.00$275,000.00View SEC Filing  
6/8/2015Lawrence P WennogleVPSell25,000$26.84$671,000.00View SEC Filing  
3/11/2015Christopher D AlafiDirectorBuy625,000$24.00$15,000,000.00View SEC Filing  
12/9/2014Lawrence J HinelineCFOSell22,500$16.71$375,975.00View SEC Filing  
12/1/2014Moshe AlafiMajor ShareholderBuy1,422$14.75$20,974.50View SEC Filing  
11/28/2014Christopher D AlafiDirectorBuy35,000$14.75$516,250.00View SEC Filing  
11/19/2014Alafi Capital Co LlcMajor ShareholderBuy1,034$14.25$14,734.50View SEC Filing  
11/18/2014Alafi Capital Co LlcMajor ShareholderBuy3,664$14.26$52,248.64View SEC Filing  
11/13/2014Alafi Capital Co LlcMajor ShareholderBuy12,200$15.34$187,148.00View SEC Filing  
11/6/2014Michael HalsteadSVPBuy20,000$15.38$307,600.00View SEC Filing  
10/15/2014Lawrence P WennogleVPSell3,604$15.00$54,060.00View SEC Filing  
10/13/2014Lawrence P WennogleVPSell1,600$15.00$24,000.00View SEC Filing  
10/8/2014Lawrence P WennogleVPSell4,745$15.00$71,175.00View SEC Filing  
10/6/2014Lawrence P WennogleVPSell16,499$15.00$247,485.00View SEC Filing  
9/15/2014Lawrence P WennogleVPSell5,000$15.00$75,000.00View SEC Filing  
9/8/2014Lawrence J HinelineCFOSell300$15.00$4,500.00View SEC Filing  
5/22/2014Lawrence P WennogleVPSell6,000$15.00$90,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Intra-Cellular Therapies (NASDAQ:ITCI)
DateHeadline
investornewswire.com logoIntra-Cellular Therapies Inc. (NASDAQ:ITCI) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:ITCI)
www.investornewswire.com - August 26 at 5:34 PM
capitalcube.com logoIntra-Cellular Therapies, Inc. breached its 50 day moving average in a Bearish Manner : ITCI-US : August 26, 2016 (NASDAQ:ITCI)
www.capitalcube.com - August 26 at 8:41 AM
News IconCrowd is Weighing in on Intra-Cellular Therapies Inc. (NASDAQ:ITCI) - Post News (NASDAQ:ITCI)
www.kentuckypostnews.com - August 21 at 5:12 PM
capitalcube.com logoETF’s with exposure to Intra-Cellular Therapies, Inc. : August 18, 2016 (NASDAQ:ITCI)
www.capitalcube.com - August 19 at 8:42 AM
investornewswire.com logoWill Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Hit $95 Price Target? - Investor Newswire (NASDAQ:ITCI)
www.investornewswire.com - August 18 at 5:44 PM
realistinvestor.com logoAnalysts See Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Reporting EPS Of $-0.95 - RealistInvestor.com (NASDAQ:ITCI)
www.realistinvestor.com - August 18 at 5:44 PM
finance.yahoo.com logoINTRA-CELLULAR THERAPIES, INC. Financials (NASDAQ:ITCI)
finance.yahoo.com - August 12 at 5:49 PM
equities.com logoIntra-Cellular Therapies Inc. (ITCI) is Trading Higher on Unusual Volume for August 08 - Equities.com (NASDAQ:ITCI)
www.equities.com - August 10 at 8:37 AM
fortune.com logoNotable Analyst Coverage: SUPERVALU INC. (NYSE:SVU), Intra-Cellular Therapies Inc (NASDAQ:ITCI) - Review Fortune (NASDAQ:ITCI)
reviewfortune.com - August 9 at 5:53 PM
News IconBiggest Healthcare Movers: Exact Sciences Corporation (NASDAQ:EXAS), Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - TWN (NASDAQ:ITCI)
thewellesleysnews.com - August 9 at 5:53 PM
capitalcube.com logoETF’s with exposure to Intra-Cellular Therapies, Inc. : August 8, 2016 (NASDAQ:ITCI)
www.capitalcube.com - August 8 at 5:54 PM
marketnewsvideo.com logoNoteworthy Friday Option Activity: CPSI, BA, ITCI (NASDAQ:ITCI)
www.marketnewsvideo.com - August 6 at 8:36 AM
capitalcube.com logoIntra-Cellular Therapies, Inc. :ITCI-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016 (NASDAQ:ITCI)
www.capitalcube.com - August 5 at 5:52 PM
sg.finance.yahoo.com logoIntra-Cellular reports 2Q loss (NASDAQ:ITCI)
sg.finance.yahoo.com - August 4 at 6:01 PM
finance.yahoo.com logo7:06 am Intra-Cellular Therapies beats by $0.08, beats on revs (NASDAQ:ITCI)
finance.yahoo.com - August 4 at 8:46 AM
biz.yahoo.com logoINTRA-CELLULAR THERAPIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Finan (NASDAQ:ITCI)
biz.yahoo.com - August 4 at 8:46 AM
publicnow.com logoIntra-Cellular Therapies Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:ITCI)
www.publicnow.com - August 4 at 8:46 AM
investornewswire.com logoCan Shares Of Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Hit $95? - Investor Newswire (NASDAQ:ITCI)
www.investornewswire.com - July 28 at 8:44 AM
publicnow.com logoIntra-Cellular Therapies to Host Second Quarter 2016 Financial Results Conference Call and Webcast (NASDAQ:ITCI)
www.publicnow.com - July 25 at 8:18 AM
News IconWere Analysts Bearish Intra-Cellular Therapies Inc (NASDAQ:ITCI) This Week? - Consumer Eagle (NASDAQ:ITCI)
www.consumereagle.com - July 22 at 5:38 PM
news.cmlviz.com logoIntra-Cellular Therapies Inc (NASDAQ:ITCI) Stock Technicals Hit Strength - CML News (NASDAQ:ITCI)
news.cmlviz.com - July 22 at 5:38 PM
News IconShares Positive Over the Past Month: Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - TGP (NASDAQ:ITCI)
telanaganapress.com - July 20 at 8:43 AM
News IconEquity Roundup: Stock Performance Focus on Intra-Cellular Therapies Inc. (NASDAQ:ITCI) - Press Telegraph (NASDAQ:ITCI)
presstelegraph.com - July 19 at 11:49 AM
News IconStock in Positive Territory for the Quarter: Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - Engelwood Daily (NASDAQ:ITCI)
www.engelwooddaily.com - July 18 at 5:53 PM
News IconShares Experiencing a Downtrend: Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - TGP (NASDAQ:ITCI)
telanaganapress.com - July 17 at 5:15 PM
News IconCrowd Rating and Earnings Recap for Intra-Cellular Therapies Inc. (NASDAQ:ITCI) - Telanagana Press (NASDAQ:ITCI)
telanaganapress.com - July 15 at 9:25 AM
News IconIntra Cellular Therapies Incorporated (NASDAQ:ITCI) Sellers Increased By 1.35% Their Shorts - Consumer Eagle (NASDAQ:ITCI)
www.consumereagle.com - July 15 at 9:25 AM
News IconIntra-Cellular Therapies Inc. (NASDAQ:ITCI) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:ITCI)
telanaganapress.com - July 14 at 9:16 AM
investornewswire.com logoStrong Sell Calls For Intra-Cellular Therapies Inc. (NASDAQ:ITCI) At 0 - Investor Newswire (NASDAQ:ITCI)
www.investornewswire.com - July 14 at 9:16 AM
News IconTrading Performance and Target Watch for Intra-Cellular Therapies Inc. (NASDAQ:ITCI) - Press Telegraph (NASDAQ:ITCI)
presstelegraph.com - July 13 at 8:38 AM
News IconHow Analysts Rated Intra-Cellular Therapies Inc (NASDAQ:ITCI) Last Week? - Consumer Eagle (NASDAQ:ITCI)
www.consumereagle.com - July 13 at 8:37 AM
News IconRedmile Group LLC Decreased Stake in Intra Cellular Therapies INC (NASDAQ:ITCI) by $4.53 Million as Shares ... - Engelwood Daily (NASDAQ:ITCI)
www.engelwooddaily.com - July 11 at 5:47 PM
News IconCompany Stock Focus for Intra-Cellular Therapies Inc. (NASDAQ:ITCI): Which Way Will Shares Head? - Press Telegraph (NASDAQ:ITCI)
presstelegraph.com - July 11 at 5:47 PM
nasdaq.com logoBullish Two Hundred Day Moving Average Cross - ITCI (NASDAQ:ITCI)
www.nasdaq.com - July 8 at 5:52 PM
biz.yahoo.com logoINTRA-CELLULAR THERAPIES, INC. Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders (NASDAQ:ITCI)
biz.yahoo.com - July 7 at 4:23 PM
News IconIntra-Cellular Therapies Inc. (NASDAQ:ITCI) Stock Update: Check on Ratings and Target Price - Telanagana Press (NASDAQ:ITCI)
telanaganapress.com - July 7 at 8:37 AM
investornewswire.com logoIntra-Cellular Therapies Inc. (NASDAQ:ITCI) Expected to Reach Highs Of $95 - Investor Newswire (NASDAQ:ITCI)
www.investornewswire.com - July 7 at 8:37 AM
News IconStock Rating Watch and Earnings Insight for Intra-Cellular Therapies Inc. (NASDAQ:ITCI) - Press Telegraph (NASDAQ:ITCI)
presstelegraph.com - July 6 at 10:24 AM
publicnow.com logoIntra-Cellular Therapies to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference (NASDAQ:ITCI)
www.publicnow.com - July 6 at 8:11 AM
finance.yahoo.com logoIntra-Cellular Therapies to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference (NASDAQ:ITCI)
finance.yahoo.com - July 6 at 8:00 AM
News IconCan Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:ITCI)
www.engelwooddaily.com - July 5 at 5:37 PM
insidermonkey.com logoAre Markets Finally Starting To See Intra-Cellular Therapies, Inc. (ITCI)'s Billion-Dollar Potential? - Insider Monkey (blog) (NASDAQ:ITCI)
www.insidermonkey.com - June 30 at 8:36 AM
biz.yahoo.com logoINTRA-CELLULAR THERAPIES, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:ITCI)
biz.yahoo.com - June 30 at 8:15 AM
publicnow.com logoIntra-Cellular Therapies Reports Completion of Enrollment of ITI-007-302 Phase 3 Clinical Trial for the Treatment of Schizophrenia (NASDAQ:ITCI)
www.publicnow.com - June 30 at 7:21 AM
investornewswire.com logoStrong Sell Calls Recommendations For Intra-Cellular Therapies Inc. (NASDAQ:ITCI) At 0 - Investor Newswire (NASDAQ:ITCI)
www.investornewswire.com - June 29 at 5:38 PM
News IconAre Markets Finally Starting To See Intra-Cellular Therapies, Inc. (ITCI)’s Billion-Dollar Potential? (NASDAQ:ITCI)
feedproxy.google.com - June 29 at 1:22 PM
News IconCheck on Share Volatility: Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - Engelwood Daily (NASDAQ:ITCI)
www.engelwooddaily.com - June 29 at 8:31 AM
News IconIntra-Cellular Therapies Inc. (NASDAQ:ITCI) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:ITCI)
www.engelwooddaily.com - June 28 at 10:35 AM
streetinsider.com logoIntra-Cellular Therapies (ITCI) Initiated Phase 3 Development of ITI-007 for Dementia - StreetInsider.com (NASDAQ:ITCI)
www.streetinsider.com - June 28 at 10:35 AM
News IconTop Stock Pick for Quarter: Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - Engelwood Daily (NASDAQ:ITCI)
www.engelwooddaily.com - June 28 at 10:35 AM

Social

Intra-Cellular Therapies (NASDAQ:ITCI) Chart for Monday, August, 29, 2016


Last Updated on 8/29/2016 by MarketBeat.com Staff